Adrenal insufficiency: Patients should have steroid injections at home to prevent hospital admission, says NICE  BMJ. 2024;386:q1893
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39209514

Advances in the study of microparticles in diabetic retinopathy  Postgraduate Medical Journal. 2024;100(1187):626-634
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38572927

All-cause and cause-specific mortality risk and loss in life expectancy associated with incident type 2 diabetes onset age and duration  Journal of Internal Medicine. 2024;296(3):260-279
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39021307

CAHtalyzing Change in Congenital Adrenal Hyperplasia  New England Journal of Medicine. 2024;391(6):559-561
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39115066

Can short- and long-term maternal and infant risks linked to hypertension and diabetes during pregnancy be reduced by therapy?  Journal of Internal Medicine. 2024;296(3):216-233
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39045893

Decreased glucagon in diabetic peripheral neuropathy patients with long duration type 2 diabetes  Postgraduate Medical Journal. 2024;100(1187):686-691
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38646729

Diabetes-Associated Scleredema  New England Journal of Medicine. 2024;391(8):e15
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39167810

Endometriosis Typology and Ovarian Cancer Risk  JAMA. 2024;332(6):482-489
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39018030

Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword  New England Journal of Medicine. 2024;391(8):770-772
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39167815

An Evaluation of the Efficacy of Machine Learning in Predicting Thyrotoxicosis and Hypothyroidism: A Comparative Assessment of Biochemical Test Parameters Used in Different Health Checkups  Internal Medicine. 2024;63(16):2259-2268
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38171877

Fasting, Meal Substitute Improved Blood Sugar More Than Diabetes Drugs  JAMA. 2024;332(5):362-363
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38995658

Guidelines May Fall Short as More Older Adults Live With Type 1 Diabetes  JAMA. 2024;332(5):363
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38995640

Hot Water Eliminates the Bitter Taste of Oral Semaglutide: A Report of Four Cases  Internal Medicine. 2024;63(16):2297-2300
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38220187

How Would You Treat This Inpatient With Type 2 Diabetes Mellitus? Grand Rounds Discussion From Beth Israel Deaconess Medical Center  Annals of Internal Medicine. 2024;177(8):1106-1117
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39133925

International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches  Lancet. 2024;404(10455):902-906
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39159651

New Data on GLP-1s, Diabetic Retinopathy, and CGMs-Highlights From the ADA’s Scientific Sessions  JAMA. 2024;332(7):519-521
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39058476

New Insights in Endometriosis Subtypes and Ovarian Cancer Risk  JAMA. 2024;332(6):460-461
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39018063

Pancreatic Neuroendocrine Neoplasm Concomitant with Branch-duct Intraductal Papillary Mucinous Neoplasm: A Case Report and Literature Review  Internal Medicine. 2024;63(17):2427-2432
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38296477

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia  New England Journal of Medicine. 2024;391(6):504-514
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38828955

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia  New England Journal of Medicine. 2024;391(6):493-503
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38828945

Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection  JAMA. 2024;332(6):501-502
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39008327

Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study  BMJ. 2024;386:e079475
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39197881

SGLT-2 inhibitors and dementia  BMJ. 2024;386:q1841
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39197937

SGLT-2 inhibitors for diabetes may help prevent dementia, study finds  BMJ. 2024;386:q1875
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39197877

Type 2 Diabetes in Patients with G6PD Deficiency  New England Journal of Medicine. 2024;391(6):568-569
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39115068